Skip to main content
Erschienen in: AIDS and Behavior 9/2019

21.02.2019 | Original Paper

Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort Study

verfasst von: Ryan P. Westergaard, Karli R. Hochstatter, Paige N. Andrews, Danielle Kahn, Casey L. Schumann, Alec E. Winzenried, Ajay K. Sethi, Ronald E. Gangnon, James M. Sosman

Erschienen in: AIDS and Behavior | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Antiretroviral therapy is successfully administered to people living with HIV while they are incarcerated in most US prison systems, but interruptions in treatment are common after people are released. We undertook an observational cohort study designed to examine the clinical and psychosocial factors that influence linkage to HIV care and viral suppression after release from a single state prison system. In this report we describe baseline characteristics and 6-month post-incarceration HIV care outcomes for 170 individuals in Wisconsin. Overall, 114 (67%) individuals were linked to outpatient HIV care within 180 days of release from prison, and of these, 90 (79%) were observed to have HIV viral suppression when evaluated in the community. The strongest predictor of linkage to care in this study was participation in a patient navigation program: Those who received patient navigation were linked to care 84% of the time, compared to 60% of the individuals who received only standard release planning (adjusted OR 3.69, 95% CI 1.24, 10.96; P < 0.01). Findings from this study demonstrate that building and maintaining intensive patient navigation programs that support individuals releasing from prison is beneficial for improving transitions in HIV care.
Literatur
1.
Zurück zum Zitat Dolan K, Wirtz AL, Moazen B, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089–102.CrossRef Dolan K, Wirtz AL, Moazen B, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089–102.CrossRef
2.
Zurück zum Zitat Altice FL, Azbel L, Stone J, et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet. 2016;388(10050):1228–48.CrossRef Altice FL, Azbel L, Stone J, et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet. 2016;388(10050):1228–48.CrossRef
4.
Zurück zum Zitat Springer SA, Friedland GH, Doros G, Pesanti E, Altice FL. Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clin Trials. 2007;8(4):205–12.CrossRef Springer SA, Friedland GH, Doros G, Pesanti E, Altice FL. Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clin Trials. 2007;8(4):205–12.CrossRef
5.
Zurück zum Zitat Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med. 2014;174(5):721–9.CrossRef Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med. 2014;174(5):721–9.CrossRef
6.
Zurück zum Zitat Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725–31.CrossRef Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725–31.CrossRef
7.
Zurück zum Zitat Baillargeon J, Giordano TP, Rich JD, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301(8):848–57.CrossRef Baillargeon J, Giordano TP, Rich JD, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301(8):848–57.CrossRef
8.
Zurück zum Zitat Milloy MJ, Kerr T, Buxton J, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–21.CrossRef Milloy MJ, Kerr T, Buxton J, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–21.CrossRef
9.
Zurück zum Zitat Meyer JP, Cepeda J, Springer SA, Wu J, Trestman RL, Altice FL. HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study. Lancet HIV. 2014;1(2):e77–84.CrossRef Meyer JP, Cepeda J, Springer SA, Wu J, Trestman RL, Altice FL. HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study. Lancet HIV. 2014;1(2):e77–84.CrossRef
10.
Zurück zum Zitat Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala. Uganda AIDS. 2007;21(8):965–71.PubMed Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala. Uganda AIDS. 2007;21(8):965–71.PubMed
12.
Zurück zum Zitat Flanigan TP. Jails: the new frontier. HIV testing, treatment, and linkage to care after release. AIDS Behav. 2013;17(Suppl 2):S83–5.CrossRef Flanigan TP. Jails: the new frontier. HIV testing, treatment, and linkage to care after release. AIDS Behav. 2013;17(Suppl 2):S83–5.CrossRef
13.
Zurück zum Zitat Beyrer CA, Kamarulzaman A, McKee M. Prisoners, prisons, and HIV: time for reform. Lancet. 2016;388(10049):1033–5.CrossRef Beyrer CA, Kamarulzaman A, McKee M. Prisoners, prisons, and HIV: time for reform. Lancet. 2016;388(10049):1033–5.CrossRef
14.
Zurück zum Zitat Small W, Wood E, Betteridge G, Montaner J, Kerr T. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21(6):708–14.CrossRef Small W, Wood E, Betteridge G, Montaner J, Kerr T. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21(6):708–14.CrossRef
15.
Zurück zum Zitat Brinkley-Rubinstein L. Incarceration as a catalyst for worsening health. Health Justice. 2013;1(1):3.CrossRef Brinkley-Rubinstein L. Incarceration as a catalyst for worsening health. Health Justice. 2013;1(1):3.CrossRef
16.
Zurück zum Zitat Wisconsin Department of Health Services, D.o.P.H.A.H.P., Wisconsin HIV Surveillance Annual Review. 2018. Wisconsin Department of Health Services, D.o.P.H.A.H.P., Wisconsin HIV Surveillance Annual Review. 2018.
18.
Zurück zum Zitat Pawasarat JQ, Lois M. Wisconsin’s mass incarceration of African American males. Summary: ETI Publications; 2014. Pawasarat JQ, Lois M. Wisconsin’s mass incarceration of African American males. Summary: ETI Publications; 2014.
22.
Zurück zum Zitat Sun S, Crooks N, Kemnitz R, Westergaard RP. Re-entry experiences of Black men living with HIV/AIDS after release from prison: intersectionality and implications for care. Soc Sci Med. 2018;211:78–86.CrossRef Sun S, Crooks N, Kemnitz R, Westergaard RP. Re-entry experiences of Black men living with HIV/AIDS after release from prison: intersectionality and implications for care. Soc Sci Med. 2018;211:78–86.CrossRef
23.
Zurück zum Zitat Kemnitz R, Kuehl TC, Hochstatter KR. Manifestations of HIV stigma and their impact on retention in care for people transitioning from prisons to communities. Health & Justice. 2017;5(1):7–9.CrossRef Kemnitz R, Kuehl TC, Hochstatter KR. Manifestations of HIV stigma and their impact on retention in care for people transitioning from prisons to communities. Health & Justice. 2017;5(1):7–9.CrossRef
24.
Zurück zum Zitat Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105(7):e5–16.CrossRef Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105(7):e5–16.CrossRef
25.
Zurück zum Zitat Chu C, Umanski G, Blank A, Meissner P, Grossberg R, Selwyn PA. Comorbidity-related treatment outcomes among HIV-infected adults in the Bronx, NY. J Urban Health. 2011;88(3):507–16.CrossRef Chu C, Umanski G, Blank A, Meissner P, Grossberg R, Selwyn PA. Comorbidity-related treatment outcomes among HIV-infected adults in the Bronx, NY. J Urban Health. 2011;88(3):507–16.CrossRef
26.
Zurück zum Zitat Rodriguez-Penney AT, Iudicello JE, Riggs PK, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDs. 2013;27(1):5–16.CrossRef Rodriguez-Penney AT, Iudicello JE, Riggs PK, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDs. 2013;27(1):5–16.CrossRef
27.
Zurück zum Zitat Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7.CrossRef Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7.CrossRef
28.
Zurück zum Zitat Greenberg GA, Rosenheck RA. Homelessness in the state and federal prison population. Crim Behav Ment Health. 2008;18(2):88–103.CrossRef Greenberg GA, Rosenheck RA. Homelessness in the state and federal prison population. Crim Behav Ment Health. 2008;18(2):88–103.CrossRef
29.
Zurück zum Zitat Kerker BD, Bainbridge J, Kennedy J, et al. A population-based assessment of the health of homeless families in New York City, 2001-2003. Am J Public Health. 2011;101(3):546–53.CrossRef Kerker BD, Bainbridge J, Kennedy J, et al. A population-based assessment of the health of homeless families in New York City, 2001-2003. Am J Public Health. 2011;101(3):546–53.CrossRef
30.
Zurück zum Zitat Robertson MJ, Clark RA, Charlebois ED, et al. HIV seroprevalence among homeless and marginally housed adults in San Francisco. Am J Public Health. 2004;94(7):1207–17.CrossRef Robertson MJ, Clark RA, Charlebois ED, et al. HIV seroprevalence among homeless and marginally housed adults in San Francisco. Am J Public Health. 2004;94(7):1207–17.CrossRef
31.
Zurück zum Zitat Milloy MJ, Marshall BD, Montaner J, Wood E. Housing status and the health of people living with HIV/AIDS. Curr HIV/AIDS Rep. 2012;9(4):364–74.CrossRef Milloy MJ, Marshall BD, Montaner J, Wood E. Housing status and the health of people living with HIV/AIDS. Curr HIV/AIDS Rep. 2012;9(4):364–74.CrossRef
32.
Zurück zum Zitat Montague BT, John B, Sammartino C, et al. Use of viral load surveillance data to assess linkage to care for persons with HIV released from corrections. PLoS ONE. 2018;13(2):e0192074.CrossRef Montague BT, John B, Sammartino C, et al. Use of viral load surveillance data to assess linkage to care for persons with HIV released from corrections. PLoS ONE. 2018;13(2):e0192074.CrossRef
33.
Zurück zum Zitat Hochstatter KR, Hull SJ, Stockman LJ, et al. Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients: experience from a pilot intervention. Int J Drug Policy. 2017;42:22–5.CrossRef Hochstatter KR, Hull SJ, Stockman LJ, et al. Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients: experience from a pilot intervention. Int J Drug Policy. 2017;42:22–5.CrossRef
34.
Zurück zum Zitat Harrigan PR, Whaley M, Montaner JS. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS. 1999;13(8):F59–62.CrossRef Harrigan PR, Whaley M, Montaner JS. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS. 1999;13(8):F59–62.CrossRef
Metadaten
Titel
Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort Study
verfasst von
Ryan P. Westergaard
Karli R. Hochstatter
Paige N. Andrews
Danielle Kahn
Casey L. Schumann
Alec E. Winzenried
Ajay K. Sethi
Ronald E. Gangnon
James M. Sosman
Publikationsdatum
21.02.2019
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 9/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02437-4

Weitere Artikel der Ausgabe 9/2019

AIDS and Behavior 9/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.